IP Library Assignment 052997/0781
Patent Assignment
Reel/Frame 052997/0781

Assignment of Assignor's Interest

Recorded: 2020-06-22 Pages: 8
Assignor
ONCOQUEST INC.
Executed: 2020-06-09
Assignee
ONCOQUEST PHARMACEUTICALS INC.
670-21 SANNAE-RO, SANNAE-MYEON, MIRYANG-SI, KOREA, REPUBLIC OF
Covered Properties (14)
Method and Composition for Reconforming Multi-Epitopic Antigens to Initiate an Immune Response
Patent: 6,241,985 →
Application: 08/913,290 →
Therapeutic Binding Agents Against Muc-1 Antigen and Methods for Their Use
Patent: 6,716,966 →
Application: 09/641,833 →
Therapeutic Method and Composition Utilizing Antigen-Antibody Complexation and Presentation by Dendritic Cells
Patent: 6,689,355 →
Application: 09/853,268 →
Publication: US 2002/0164312
Therapeutic Binding Agents Against Muc-1 Antigen and Methods for Their Use
Patent: 7,147,850 →
Application: 09/994,466 →
Publication: US 2002/0132771
Combination Therapy for Treating Disease
Patent: 8,038,994 →
Application: 10/831,886 →
Publication: US 2005/0063976
Ige Antibodies for the Treatment of Cancer
Patent: 8,697,079 →
Application: 13/372,557 →
Publication: US 2013/0022614
METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE
Patent: 8,945,566 →
Application: 13/456,492 →
Publication: US 2013/0058920
Tumor Antigen Specific Antibodies and TLR3 Stimulation to Enhance the Performance of Checkpoint Interference Therapy of Cancer
Application: 15/501,773 →
Publication: US 2017/0226221
Methods of Increasing Delivery of Anti-Cancer Agents to Targets
Application: 15/541,451 →
Publication: US 2018/0002441
Treatment of Cancer with Therapeutic Monoclonal Antibody Specific for a Tumor Associated Antigen and an Immune Adjuvant
Application: 15/654,415 →
Publication: US 2018/0221477
Tumor Antigen Specific Antibodies and TLR3 Stimulation to Enhance the Performance of Checkpoint Interference Therapy of Cancer
Application: 16/448,453 →
Publication: US 2019/0322760
Method of Indirect Immunization of Human Ovarian Cancer Patients Through Selection of Xenogeneic Immunoglobulin Fc Portions
Application: 16/482,163 →
Publication: US 2020/0093925
Treatment of Cancer with Therapeutic Monoclonal Antibody Specific for a Tumor Associated Antigen and an Immune Adjuvant
Application: 16/702,323 →
Publication: US 2020/0101159
Treatment of Cancer with Therapeutic Monoclonal Antibody Specific for a Tumor Associated Antigen and an Immune Adjuvant
Application: 62/455,114 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Aug 21, 2006
From: UNIVERSITY OF MARYLAND BALT PROF SCHOOL
To: US GOVERNMENT - SECRETARY FOR THE ARMY
Reel/Frame 018148/0247 →
Assignment of Assignor's Interest Aug 25, 2011
From: ALTAREX MEDICAL CORP.
To: QUEST PHARMATECH INC.
Reel/Frame 026808/0869 →
Confirmatory License May 16, 2012
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028215/0247 →
Assignment of Assignor's Interest Dec 18, 2012
From: ADVANCED IMMUNE THERAPEUTICS, INC.
To: QUEST PHARMATECH, INC.
Reel/Frame 029488/0088 →
Assignment of Assignor's Interest Jan 28, 2013
From: ADVANCED IMMUNE THERAPEUTICS, INC.
To: QUEST PHARMATECH INC.
Reel/Frame 029703/0716 →
Assignment of Assignor's Interest Jun 6, 2013
From: ALTAREX MEDICAL CORP.
To: QUEST PHARMATECH INC.
Reel/Frame 030573/0225 →
Assignment of Assignor's Interest Jul 31, 2013
From: PENICHET, MANUEL L.; DANIELS, TRACY R.; HELGUERA, GUSTAVO; RODRIGUEZ, JOSE A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030915/0588 →
Assignment of Assignor's Interest Nov 5, 2015
From: QUEST PHARMATECH INC.
To: ONCOQUEST INC.
Reel/Frame 036971/0776 →
Assignment of Assignor's Interest Dec 7, 2015
From: SCHULTES, BIRGIT C.; NICODEMUS, CHRISTOPHER F.
To: ADVANCED IMMUNE THERAPEUTICS, INC.
Reel/Frame 037222/0001 →
Assignment of Assignor's Interest Dec 7, 2015
From: QUEST PHARMATECH INC.
To: ONCOQUEST INC.
Reel/Frame 037221/0793 →
Assignment of Assignor's Interest Dec 7, 2015
From: SCHULTES, BIRGIT; NICODEMUS, CHRISTOPHER F.
To: ADVANCED IMMUNE THERAPEUTICS, INC.
Reel/Frame 037222/0024 →
Assignment of Assignor's Interest Feb 9, 2016
From: ALTAREX MEDICAL CORP.
To: QUEST PHARMATECH INC.
Reel/Frame 037690/0786 →
Assignment of Assignor's Interest Feb 8, 2017
From: QUEST PHARMATECH, INC.
To: ONCOQUEST, INC.
Reel/Frame 041205/0114 →
Assignment of Assignor's Interest Feb 8, 2017
From: MADIYALAKAN, RAGUPATHY; NICODEMUS, CHRISTOPHER F
To: QUEST PHARMATECH., INC.
Reel/Frame 041205/0054 →
Assignment of Assignor's Interest Nov 30, 2017
From: NICODEMUS, CHRISTOPHER F; MADIYALAKAN, RAGUPATHY
To: ONCOQUEST INC.
Reel/Frame 044260/0178 →
Assignment of Assignor's Interest May 25, 2018
From: MADIYALAKAN, RAGUPATHY; NICODEMUS, CHRISTOPHER F.
To: QUEST PHARMATECH INC.
Reel/Frame 045901/0391 →
Assignment of Assignor's Interest May 25, 2018
From: HOLLINGSWORTH, MICHAEL A.
To: QUEST PHARMATECH INC.
Reel/Frame 045901/0580 →
Assignment of Assignor's Interest Jul 10, 2019
From: MADIYALAKAN, RAGUPATHY; NICODEMUS, CHRISTOPHER F.
To: ONCOQUEST INC.
Reel/Frame 049714/0894 →
Assignment of Assignor's Interest Sep 11, 2019
From: MADIYALAKAN, RAGUPATHY; NICODEMUS, CHRISTOPHER F.
To: ONCOQUEST INC.
Reel/Frame 050342/0281 →
Assignment of Assignor's Interest Dec 4, 2019
From: NICODEMUS, CHRISTOPHER F.; MADIYALAKAN, RAGUPATHY
To: ONCOQUEST INC.
Reel/Frame 051175/0914 →
Assignment of Assignor's Interest Jan 10, 2020
From: QUEST PHARMATECH INC.
To: ONCOQUEST INC.
Reel/Frame 051478/0383 →
Assignment of Assignor's Interest Jun 23, 2022
From: ONCOQUEST PHARMACEUTICALS INC.
To: OQP BIO INC.
Reel/Frame 060293/0424 →
Assignment of Assignor's Interest Jun 23, 2022
From: OQP BIO INC.
To: MH C&C INC.
Reel/Frame 060293/0701 →
Change of Name Oct 13, 2022
From: MH C&C INC.
To: CANARIABIO INC.
Reel/Frame 061680/0252 →